|Pre-Exposure Prophylaxis: Efficacy to Implementation|
|Stephanie Cohen, MD, MPH, Medical Director, City Clinic, San Francisco Department of Public Health, Assistant Clinical Professor, UCSF, Division of Infectious Diseases|
February 20, 2013
Dr. Cohen discusses pre-exposure antiretroviral prophylaxis (PrEP) and the San Francisco Department of Public Health's Demo Project, a study on PrEP implementation among high-risk men who have sex with men (MSM). In her presentation, she reviews efficacy data, lists outstanding research questions related to PrEP, and discusses PrEP implementation studies, as well as how The Demo Project seeks to answer key questions about using PrEP in practice.
| Presenter: Stephanie Cohen, MD, MPH|
Stephanie Cohen is the medical director of San Francisco City Clinic, the San Francisco Department of Public Health's STD clinic, and an assistant professor in the Division of Infectious Disease at UCSF. Her interests include translating STD and HIV prevention research into clinical and public health practice. She is a protocol Co-Chair and site Co-Principal Investigator of The Demo Project, an NIH-funded research study assessing the delivery of pre-exposure prophylaxis (PrEP) in STD and community health clinics.
| Optional Posttest|
The activity consists of a slideshow accompanied by audio that can be viewed or browsed by all users. Users may also complete a posttest to test what they have learned. |